SUBCUT HF II: a multicentre randomised controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure
9 May 2026 (13:15 - 13:24)
Organised by: 
Slides
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
9 More presentations in this session
Doctor I. Taraldsen (Copenhagen, DK)
Professor S. Rosenkranz (Cologne, DE)
Access the full session
The Event
Heart Failure 2026
9 May 2026
13:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
28 August 2023
